Literature DB >> 843420

Effects of (+) and (-)-propranolol on the responses of the human isolated basilar artery to cerebrospinal fluid obtained from patients with subarachnoid haemorrhage and cerebral arterial spasm.

D J Boullin, J Mohan.   

Abstract

1. The human isolated basilar artery has been used as a model to investigate the aetiology of cerebral arterial spasm associated with rupture of intracranial aneurysms. 2. The isolated artery is contracted by 5-hydroxytryptamine, noradrenaline, six prostaglandins and cerebrospinal fluid from patients with ruptured aneurysms and cerebral arterial spasm. 3. These contractions are reversed by (+/-)--, (+)-- and (--)-propranolol in concentrations known to produce local anaesthetic effects on isolated frog sciatic nerve; the (+) isomer was 2.5 to 10 times more potent (-)-propranolol in antagonising all contractions. 4. As the two isomers are known to have similar local anaesthetic potency but (-)-propranolol has greater beta-adrenoreceptor blocking effects we conclude that the antagonistic effects described do not involve beta-adrenoreceptor blockade. 5. The data indicate that propranolol may be of clinical use in reversing cerebral arterial spasm.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843420      PMCID: PMC1428990          DOI: 10.1111/j.1365-2125.1977.tb00662.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

Review 1.  Cerebral arterial spasm: current concepts.

Authors:  J T Robertson
Journal:  Clin Neurosurg       Date:  1974

Review 2.  Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

3.  Cerebral arteriolar spasm inhibited by beta-adrenergic blocking agents.

Authors:  W I Rosenblum
Journal:  Arch Neurol       Date:  1969-09

4.  Effects of beta-adrenergic blockade on cerebral autoregulation and chemical vasomotor control in patients with stroke.

Authors:  J S Meyer; S Okamoto; A Sari; A Koto; Y Itoh; A D Ericsson
Journal:  Stroke       Date:  1974 Mar-Apr       Impact factor: 7.914

Review 5.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

6.  Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes.

Authors:  L M Starling; D J Boullin; D G Grahame-Smith; C B Adams; R S Gye
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-07       Impact factor: 10.154

7.  Propranolol in the control of schizophrenic symptoms.

Authors:  N J Yorkston; S A Zaki; M K Malik; R C Morrison; C W Havard
Journal:  Br Med J       Date:  1974-12-14
  7 in total
  2 in total

1.  Aetiology of cerebral arterial spasm following subarachnoid haemorrhage: evidence against a major involvement of 5-hydroxy-tryptamine in the production of acute spasm.

Authors:  D J Boullin; G H Du Boulay; A T Rogers
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

2.  Relationship between presence of vasoconstrictor activity in cerebrospinal fluid and time after subarachnoid haemorrhage from rupture of cerebral arterial aneurysms.

Authors:  T M Hunt; G H Du Boulay; W P Blaso; D M Forster; D J Boullin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-07       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.